Filter By:
- Year
-
Scheme
AIIHPC Structured Research Network APA Cycle 2 2019 Applied Partnership Awards Applied Research Projects in Dementia Applying Research into Policy & Practice Postdoctoral Fellowships ARPP 2020 Cancer Prevention Fellowship Programme Cancer Prevention Fellowship Programme Reintegration Grant Capacity Building for Evidence Synthesis Clinical Research Facilities/Centres 2021 Cochrane Training Fellowships Collaborative Doctoral Awards Conference and Event Sponsorship Scheme COVID-19 2020 CSF 2020 DIFA - 2018 DIFA 2017 DIFA 2018 DIFA 2020 DIFA-2018 Emerging Clinician Scientist Awards 2020 Emerging Investigator Awards Emerging Investigator Awards for Health (EIA) 2022 Emerging Investigator Awards Full ERA-NET Cofund for Neuroscience Research (NEURON) ERA-NET Cofund for Personalised Medicine EU Joint Programming Initiative Framework for Safe Nurse Staffing and Skill Mix Health Research Awards Health Research Awards - Definitive Intervention Health Research Awards - Definitive Interventions Health Research Centre HRB Clinical Research Coordination Ireland HRB Clinical Research Facilities HRB Collaboration in Ireland for Clinical Effectiveness Reviews HRB Trials Methodology Research Network HRCI 2020 HRCI-HRB Joint Funding Scheme ICORG Statistics and Data Management Interdisciplinary Capacity Enhancement Awards Investigator Led Projects IPPOSI 2020 Irish Clinical Oncology Research Group Irish Network for Research in Dementia and Neurodegeneration Irish Platform for Patients Organisations Science and Industry Support Award Irish Platform for Patients' Organisations, Science and Industry Joint Programming Initiative Healthy Diet for a Healthy Life Joint Programming Initiative in Neurodegenerative Diseases Joint Programming Initiative on Antimicrobial Resistance Knowledge Exchange and Dissemination Scheme Knowledge Translation Awards Medical Education Research Grant Medical Research Charities Group Support Award MRCG-HRB Joint Funding Scheme National Children's Hospital Foundation Scheme National Clinical Trials Coordination Programme National integrated PhD programme for Medical Practitioners National Intellectual Disability Supplement to TILDA National SpR Academic Fellowship Programme/HRB Joint Funding Scheme National SpR/SR Academic Fellowship Programme Patrick Quinn Awards for Parkinson's Research PPI Ignite Awards Project Development Grants Project Development Grants in Cancer Nursing Research RCQPS COVID-19 Research Collaborative for Quality and Patient Safety Research Collaborative in Quality and Patient Safety Research Leader Awards Research Training Fellowships for Health Professionals Research Training Fellowships for Healthcare Professionals RL FA 2020 RL PA 2020 Secondary Data Analysis Projects SFI-HRB-Wellcome Biomedical Partnership SFI-HRB-Wellcome Research Partnership Structured PhD Programme in Population and Health-Services Research Education Structured PhD Programme in Population Health and Health Services Research The Irish Longitudinal Study on Ageing Trials Methodology Research Network Ulysses Research Visits US-Ireland R&D Partnership Awards WHO-SOLI-2020
-
Host Institution
Alpha One Foundation Athlone Institute of Technology Beaumont Hospital Cystinosis Foundation Ireland DCU Department of Agriculture, Food and Marine Dublin City University Dublin Dental University Hospital Dublin Institute of Technology Economic and Social Research Institute Fighting Blindness Fondazione Telethon Fraunhofer ITMP Health Information and Quality Authority Health Research Charities Ireland HSE - Letterkenny General Hospital HSE - Midland Regional Hospital at Tullamore HSE - St. Luke's Hospital (Rathgar) Institute of Technology Sligo IPPOSI Irish Blood Transfusion Service, National Blood Centre Irish Cancer Society Irish Clinical Oncology Research Group Ltd Irish Platform for Patients Organisations Science and Industry Irish Platform for Patients' Organisations, Science and Industry Irish Platform for Patients' Organisations, Science and Industry Ltd Irish Platform for Patients’ Organisations, Science and Industry Irish Thoracic Society Katholieke Universiteit Leuven Limerick Institute of Technology Mary Immaculate College Limerick Maynooth University Medical Research Charities Group Ltd Molecular Medicine Ireland National Rehabilitation Hospital National Suicide Research Foundation National University of Ireland Galway National University of Ireland, Galway National University of Ireland, Maynooth Our Lady's Hospice RCSI Royal College of Physicians of Ireland Royal College of Surgeons in Ireland Royal Victoria Eye and Ear Hospital Research Foundation Ltd St John of God's Research Foundation Limited St. James's Hospital TCD Teagasc Technological University Dublin The Alzheimer Society of Ireland The Children's Hospital of Philadelphia The Children's Medical and Research Foundation Trinity College Dublin UCD University College Cork University College Dublin University Hospitals Leuven & KU Leuven University of Auckland University of California San Francisco University of Cambridge University of Galway University of Limerick University of Oxford
Funding Awarded
51 awards
Early Identification of Suicide and Self-Harm Risk and Comorbid Mental and PHysical Disorders: An INterdisciplinary TrAining, Research and InterventioN Programme (MHAINTAIN)
MHAINTAIN will create a research-through-training network addressing the need for doctoral training and career paths, to improving early identification and intervention of suicide and self-harm risk. The aim of this interdisciplinary consortium is to improve capacity building in the assessment of risk of suicide and self-harm...
PSychosis Ireland Structured Training and Research programme (PSI-STAR)
Psychotic disorders, such as schizophrenia and bipolar disorder, occur in about 3 in a hundred people and usually start in adolescence or young adulthood, greatly disrupting a young person's life in terms of education, social relationships and career outcomes. Because of the early age of onset and...
MIRANDA- Multidisciplinary Innovation and Research Advancing Neurological care in a Digital Age
Amyotrophic Lateral Sclerosis (ALS) or Motor Neurone Disease (MND) is a degenerative disease of the nervous system, which affects one in 300 people in Ireland. Those affected lose their ability to use their arms, legs and voice, and eventually their ability to breathe. Some people also experience changes in thinking.
There...
HRB Trials Methodology Research Network (HRB-TMRN) 2021 - 2026
No summary available
Clinical Trial Feasibility Award - University of Limerick
No summary available
Clinical Trial Feasibility Award - Royal College of Surgeons in Ireland
No summary available
UCD Clinical Research Centre
No summary available
HRB Clinical Research Facility - UCC (HRB CRF-UCC)
No summary available
Wellcome HRB Clinical Research Facility at St. James's Hospital
No summary available
Children's Health Ireland
No summary available
HRB Clinical Research Facility Galway
No summary available
National Clinical Trials Office 2021 - 2024
No summary available
Social Circumstances and Epigenomics: Promoting Health in Three Countries
This project proposes an integrated set of aims and analyses of existing social and epigenetic data from three national studies of aging in the family of Health and Retirement studies (the US Health and Retirement Study (HRS), the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA), and the Irish Longitudinal Study of...
Uncovering the neural architecture underlying decisions abstracted from movements
Decision making is a core component of normal and abnormal cognitive function. Understanding the neural mechanisms of decision-making will lead to advances in the diagnosis, classification and future treatments of disorders affecting thought and control. Mathematical models of the decision process, based on bounded evidence...
Autophagy induction as a novel therapeutic strategy for MSD
The lysosomal degradation pathway of autophagy has a crucial role in different pathophysiological conditions, such as infection, neurodegenerative disorders, cancer and ageing. In particular, autophagy plays an important role in the pathophysiology of a family of inborn errors of metabolism due to defect in the activity of lysosomal...
The microbiome as an environmental trigger for autoimmune epilepsy (MICA)
Autoimmune epilepsy is a rare form of drug-resistant epilepsy characterised by frequent seizures in later life. Patients may respond to immune therapy, but causation of disease is poorly understood, and more targeted treatments are required. This gap in knowledge is the major priority for epilepsy specialists, and the area of greatest...
Elucidation of the role of SARM1 in retinal homeostasis and oxidative stress induced retinal degeneration
Photoreceptor cells found in the back of our eyes convert light into signals that allow us to see. Death of these cells and the cells that nourish them, called RPE cells, is termed retinal degeneration and is characteristic of blinding diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa. Millions of people...
Towards novel anti-infective with enhanced wound-healing for diabetic foot infections : Co2 releasing star shaped micro biocidal polymers
It is estimated that 422 million people worldwide are living with diabetes and among them, a common and serious problem is the development of diabetic foot infection. One in five patients with diabetes are hospitalised with a diabetic foot wound (DFW) at least once in their lives. Infected DFWs are treated by removal of infected tissue...
Combining Electrochemotherapy with a Toll Like receptor agonist for the treatment of lung cancer
Successful cancer treatment aims to totally eliminate the entire tumour and the risk of recurrence. Treatment currently relies on removal of the primary tumour by surgery or radiotherapy followed by control of the remaining dispersed cancer cells in the whole body usually by chemotherapy. At the Cork Cancer Research Centre (CCRC) we...
Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery for Cancer of the Lung or Oesophagus
Treatment for people with cancer of the lung or the oesophagus (food-pipe) often involves surgery. This surgery is complex and there is a high risk that patients will develop severe complications afterwards, mainly lung or heart problems, leading to a longer hospital stay and higher hospital costs, and impacting greatly on recovery and...
Evaluation of the role of MxA and ISGylation in chemosensitivity in oesophageal cancer
Many oesophageal cancers develop resistance to the drugs currently used to treat this disease. This allows the cancer cells to survive and the cancer can come back again at variable times after the initial treatment. Research already performed by this group has identified genetic differences between cancer cells that respond well to...
Incorporation of sensor technology to provide clinical meaningfulness for existing standardised measurement scales in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) also known as Motor Neurone Disease (MND) is a progressive and ultimately fatal neurodegenerative disease for which there is no cure. People with ALS experience loss of mobility and arm function, breathlessness and chest infections, loss of speech and swallow and in 30-50%, cognitive and behavioural...
Novel Neurophysical Biomarkers of Heterogeneous Network Degeneration in Motor Neuron Disease for Quantifying the Progression and Outcome in Clinical Trials
Motor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS) is a terminal neurological condition in which the neurones (neural cells) that control movement degenerate. Despite encouraging results from studies in animals, translation of new treatments to humans has been disappointing. The aim of this study is to provide scientific...
Evaluating a novel macrolide based early intervention in the clinical management of chronic infections and inflammation in Cystic Fibrosis
Chronic persistent respiratory disease is a leading cause of death worldwide. Despite years of global research, the clinical management of respiratory disease, including the life-limiting genetic disease cystic fibrosis (CF), remains a significant challenge. Treatment options are extremely limited, due in part to the increased pathogen...
Gold-drug: Targeting a novel dual inhibitor drug with gold nanoparticles for improving radiation response in oesophageal cancer
Oesophageal cancer (cancer of the food pipe) has low survival rates and a very poor response to treatment. Sadly, this cancer type is on the rise in Ireland and is linked with increasing obesity rates. Unlike many other cancer types, we are still only using treatments that have existed for decades - chemotherapy drugs with radiation...
The role of sialylated-alpha-1 antitrypsin in resolution of acute and chronic inflammation
Alpha-1-antitrypsin (AAT) deficiency (AATD) is a hereditary disorder that results in the rapid progression of lung disease, especially in smokers. Specific treatment for this disorder is available in the form of weekly intravenous injections of AAT. This is referred to as augmentation therapy and studies have shown that augmentation...
Compound library screening in a zebrafish model of MSD to identify novel therapeutic compounds
Multiple Sulfatase Deficiency (MSD) is currently an untreatable disease and while we know some of the processes inside cells that cause or influence the disease, there is still much to be understood. While progress has been made from studying simple cell culture systems, this does not tell us about how different disease changes may...
Targeting autophagy in nephropathic cystinosis
Cystinosis is a genetic disorder due to a gene defect called cystinosin, where a toxic metabolite called cysteine collects in the cells due to a defect in lysosomes. This results in the kidneys become leaky to protein, water and salts, which results in growth failure, severe dehydration and developmental delay in children. A subtype of...
The Irish Longitudinal Study of Ageing Wave 5 and 6 (TILDA)
One of the greatest demographic and social transformations facing Ireland is aging of its population, increased life expectancy and related challenges. Whereas Ireland has one of the youngest populations in the European Union, by 2046 a quarter of our population will be over 65 and the greatest increase will be in those 85 and above...
Role of TWEAK/Fn14 pathway in mediating muscle pathology in SMA
Spinal muscular atrophy (SMA) is a devastating disease caused by loss of both nerve cells and muscle function. While the nerve is the major affected cell type, therapies specifically aimed at improving muscle function ameliorate survival and/or symptoms in SMA models. Thus,developing muscle-
Application of next generation sequencing for the genetic characterisation of Irish retinal degeneration patients
A key objective of the current study is to clinically and genetically characterise an extended group of 700-800 Irish patients with inherited retinal degenerations (IRD). The team have significant prior experience in the clinical and genetic evaluation of patients with inherited retinal degenerations. They believe it is timely to...
Resolution of inflammation by metabolic reprogramming in the inflamed joint
Arthritis is a leading cause of disability that affects up to 15% of the population and is the most common cause of pain in Irish society, including children. 2% suffer from inflammatory arthritis (IA) such as rheumatoid arthritis (RA) and psoriatic arthritis (PsA). IA causes joint damage and disability and is associated with...
MicroRNAs in the mechanism of ketogenic diet therapies and as biomarkers in paediatric epilepsy
Epilepsy is a disease caused by imbalances in electrical activity in the brain. Anyone can have epilepsy but it is particular common in children. Patients experience seizures (fits), which disrupt their lives and can be directly harmful to the developing brain. Although we have a number of drugs to stop seizures, they fail to work in...
Peer-to-peer motivational interview intervention for smoking, alcohol and physical activity among at-risk adolescents in low SES communities: A feasibility trial
Unhealthy behaviours established during adolescence often persist into adulthood; we will examine the effects of training adolescents (13-18 years) in a proven method for behaviour change (motivational interviewing) for smoking cessation, alcohol consumption and exercise promotion among adolescents in low SES communities. Peer-led...
Towards host-directed therapies to overcome immune impairment in cigarette smokers during mycobacterial infection
Tuberculosis (TB) is a bacterial infection which causes approximately 1.5 million deaths worldwide each year and it is estimated that one third of the worlds'population is latently infected with TB. In this proposal we aim to investigate the role of alveolar acrophages in the immune response to TB infection. Alveolar macrophages are...
Unravelling the mechanisms of azoospermia and potential future treatments in male cystinosis patients
Cystinosis is a rare inheritable disorder in which cystine, a small protein, accumulates in all cells throughout the body. Patients suffer from progressive renal failure due to extensive proximal tubular and glomerular dysfunction, but also various endocrine organs become affected later in life. Patients can be treated with cysteamine,...
AVERT: Autoimmunity relapse prediction using multiple parallel data sources
In most causes of autoimmune disease, where the body's immune system attacks an individual's own body, the condition relapses and remits. This means that strong medications to suppress the immune system bring the patient into remission, but they remain at risk of suffering a flare of their disease. In the autoimmune kidney condition...
Pioneering advances for control of myopia in children - the SHIELD initiative
Short-sightedness (or myopia) is the commonest eye problem in Ireland and is growing all over the world. It now affects up to 90% of young adults in Asia and up to 50% in Western countries. As well as the costs and frustrations of not being able to see well without glasses, myopia is also bad for the health of our eyes. As we get older...
Ketamine for relapse prevention in recurrent depressive disorder: a randomised controlled pilot trial (The KINDRED Trial)
Depression is projected to become the second greatest cause of disability worldwide by 2020. It can be a chronic disorder, with 5-9 episodes of depression per lifetime. The first six months following successful antidepressant treatment represents the highest risk period for relapse, with 40-60% relapse rates in persons with...
Identifying the aetiology of diabetic progenitor cell dysfunction in osteoporosis
Diabetes changes how a person's body gets energy from the food they eat. When we digest food, sugar is released into the blood and is used by the body's cells for energy. People with type 1 diabetes (T1DM) do not produce insulin and are therefore not able to use the sugar in the blood for energy. Patients with T1DM have to inject...
Comparative mass spectrometric profiling of the dystrophin complexome in normal versus pathological muscles with differing degrees of fibre degeneration
Duchenne muscular dystrophy is the most commonly inherited neuromuscular disease of early childhood. The disorder affects almost exclusively boys due to the fact that the defective gene is located on the X-chromosome. The skeletal musculature, the respiratory system,the heart and the central nervous system are majorly affected in...
Bacteria in human tumours
It is becoming apparent that the relationship between humans and bacteria can influence various diseases. Deeper understanding of the bacteria that live in our body is enabling identification of i) potential causes of and ii) potential treatments for disease. The Tangney lab at the Cork Cancer Research Centre has recently discovered...
An investigation of the mechanisms lining C5orf30 with tissue damage in RA
Around 40,000 Irish people have rheumatoid arthritis (RA), around half being adults of working age. Advances in our understanding of the how joint inflammation develops in RA have resulted in greatly improved treatments with improved outcomes for most patients, particular those with severe disease. Despite these remarkable achievements...
Investigate the impact of bile aspiration on chronic respiratory infection - bile paradigm
This study proposes to investigate the unexplained link between gastro-oesophageal reflux (GOR) and severe respiratory disease. During GOR, bile, normally found in the duodenum and stomach, is refluxed to the throat and subsequently aspirated into the airways and lungs of patients. A high prevalence of this phenomenon is seen in...
Identification of drugs that can safely and effectively maintain visual function in models of inherited retinal degeneration
Inherited Retinal Degenerations (IRD) are a diverse group of conditions resulting in blindness. This is often traumatic to the affected patient and families, and can cause significant socio-economic impact. Gene or stem-cell therapy show promise as treatments for IRD. However, these approaches are hampered by high costs and treatment...
Inherited retinal degenerations: All Ireland Retinal Degenerations Partnership (AIRDP)
Retinitis Pigmentosa (RP) is the most common inherited disorder of the retina affecting approximately one in 4000 people. The symptoms of RP are night blindness, tunnel vision and reduction of central vision. Although the symptoms of RP are broadly similar in most people, the genetic causes are complex with over 50 genes being...
Altered lipid raft cholesterol content contributes to the dysregulated activity of neutrophils in alpha-1 antitrypsin deficiency
Alpha-1-antitrypsin (AAT) deficiency (AATD) is largely unrecognized and under diagnosed. This hereditary disorder results in the rapid progression of lung disease, especially in smokers. Specific treatment for this disorder is available in the form of weekly intravenous injections of AAT. This is referred to as augmentation therapy...
Alpha-1 antitrypsin deficiency: Which is important phenotype, level, activity or all three?
Alpha-1 antitrypsin (AAT) deficiency (AATD) is generally regarded as a rare condition but more recently, evidence points towards it being a condition that is relatively common but rarely diagnosed. The most severe form of this genetic disorder, where people carry two bad AAT genes (Z) is known as ZZ-AATD and this affects around 2000...
Modelling cystinosis with human stem cells and the therapeutic potential of aspartate
Cystinosis is a rare genetic disease that causes the amino acid cystine to accumulate in the body due to mutations in the CTNS gene. In its severest form, cystinosis causes kidney failure before the age of 10. Treatment is limited to cysteamine, a cystine-depleting drug, but this only slows the progression of the disease. The toxic...
Drug eluting contact lenses for cystinosis therapy
Cystinosis is a metabolic disease characterized by accumulation of cysteine crystals in various tissues including cornea. Cystinosis patients begin showing ocular symptoms at the age of 16 months and without appropriate treatment, the entire peripheral stroma and endothelium can be packed with crystals. Eventually complications such...
Restoring immune balance in patients with patients with primary Sjogrens Syndrome (pSS) by modulating microRNA expression
Sjogren's Syndrome (SS) is an autoimmune disease which affects 0.3-0.5% of people in the developed world. SS can occur at any age but is most common between the ages of 40 and 60. Women are 9 times more likely to suffer from SS than men. Specialised secretory glands that produce saliva, tears, and bowel secretions are targeted for...